dehydroepiandrosterone sulfate has been researched along with Thyroid Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giraud, P; Guyétant, S; Lorimier, G; Sommelet, D; Valo, I; Verrièle, V | 1 |
| Berg, JP; Engeland, A; Glattre, E; Jellum, E | 1 |
2 other study(ies) available for dehydroepiandrosterone sulfate and Thyroid Neoplasms
| Article | Year |
|---|---|
[Thyroid metastases of an adrenocortical carcinoma 41 years after the diagnosis of the primary tumor].
Topics: Adenocarcinoma, Clear Cell; Adrenal Cortex Neoplasms; Adrenalectomy; Antineoplastic Agents; Biomarkers, Tumor; Combined Modality Therapy; Dehydroepiandrosterone Sulfate; Humans; Hydrocortisone; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitotane; Nephrectomy; Radiotherapy, Adjuvant; Thyroid Neoplasms; Thyroidectomy; Time Factors | 2004 |
Serum dehydroepiandrosterone sulfate concentration and thyroid cancer risk: a matched case control study.
Topics: Adult; Age Factors; Carcinoma, Papillary; Case-Control Studies; Dehydroepiandrosterone Sulfate; Female; Humans; Male; Middle Aged; Odds Ratio; Prospective Studies; Risk Assessment; Sex Factors; Thyroid Neoplasms | 1999 |